Sign inJoin waitlistJoin the waitlist

Sneha Phadke

Clinical Associate Professor · University of Iowa Health Care Medical Center

Credentials: · · · · · · ·

History

University of Iowa Health Care Medical Center
Present
Roy J. and Lucille A. Carver College of Medicine
Present

Infectious Disease
University of Iowa Health Care Medical Center
2016–2018
Hematology and Medical Oncology
University of Iowa Health Care Medical Center
2013–2016
Internal Medicine
University of Kansas School of Medicine
2010–2013
DO, Kansas City University of Medicine and Biosciences, Kansas City, Mo.
Kansas City University
2006–2010

Research

Pembrolizumab Therapy Triggering an Exacerbation of Preexisting Autoimmune Disease: A Report of 2 Patient Cases
Case report · Journal of Investigative Medicine High Impact Case Reports · 2016 · First of 6 authors · Corresponding · 46 citations
Breast cancer patients from the Midwest region of the United States have reduced levels of short-chain fatty acid-producing gut bacteria
Scientific Reports · 2023 · 38 citations
Beta blockade as adjunctive breast cancer therapy: A review
Review · Critical Reviews in Oncology/Hematology · 2019 · First of 2 authors · Corresponding · 29 citations

Nicole Fleege
4 papers · 2 as a fellow
Alexandra Thomas
3 papers
Ingrid Lizarraga
3 papers
Sonia Sugg
3 papers
Amani Bashir
2 papers
Jad El Masri
2 papers · 2 as a resident
Najla Itani
2 papers · 2 as a fellow
Praveen Vikas
2 papers
Ronald Weigel
2 papers
Aditya Ravindra
1 paper · 1 as a fellow
AZ
Alexandra Zimmer
1 paper
Ami Behara
1 paper

Clinical trials

Accelerated Neuromodulation to Alleviate Cognitive Deficits Due to Cancer Therapy
Principal investigator · Completed
Sneha Phadke
2021–2023
E-Mindfulness Approaches for Living After Breast Cancer
Site PI · Recruiting · Phase 3
NRG Oncology
2025–2030
Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
Site PI · Recruiting · Phase 4
University of Illinois at Chicago
2023–2030
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Site PI · Recruiting · Phase 3
NRG Oncology
2023–2034